Preview

Current Pediatrics

Advanced search

PERTUSSIS INFECTION AMIDST ANTIGENIC DRIFTING OF BORDETELLA PERTUSSIS

Abstract

The article deals with the data, which manifests the change in the serotypes of Bordetella рertussis in St. Petersburg, as well as dynamics of biological properties of the causative agent within 1990–2004. The researchers have described the dynamics of dominating serotype changes among the hospital patients from 1.2.3. between 1990–2000 Up to 1.0.3. between 2002–2004, as well as gradual change of chromosomal d na of Bordetellae from iii to iv and pertaktin (PRN) from 1 to type 2 (antigenic drifting). Analysis of the clinical picture and treatment of the disease among 138 children, suffering from pertussis, producing strains of Bordetella рertussis of serotypes 1.2.3. and 1.2.0. (93 people) along with Bordetella рertussis of serotypes 1.0.3 (45 people) showed that biological strain mutability of Bordetella рertussis causes changes in severity and clinical course of pertussis infection, without effecting the clinicial picture of the disease. Strains of pertussis bacilla of serotypes 1.0.3., iv (during electrophoresis in pulsating gel efppbgroup, prn 2 are associated with rarer development of the severe illness forms (by 2.5 times), as well as specific complications (breathbholding and pertussis encephalopathy). The patients had no life threatening complications (respiratory standstill and convulsive disorder).
Key words: pertussis, children, antigenic drifting of Bordetella рertussis, biological strain mutability, specific complications of pertussis.

About the Authors

I.V. Babachenko
Saint-Petersburg State Pediatric Medical Academy
Russian Federation


N.N. Kurova
Recearch Institute for Epidemiology and Mikrobiology named after Pasteur, Saint-Petersburg
Russian Federation



G.Ya. Tseneva
Recearch Institute for Epidemiology and Mikrobiology named after Pasteur, Saint-Petersburg
Russian Federation


References

1. Курова Н.Н. Молекулярно-биологическая характеристика циркулирующих Bordetella pertussis, циркулирующих в период подъёма заболеваемости, и совершенствование лабораторной диагностики коклюша. Автореф. дис. … канд. мед. наук. СПб. 2003. 23 с.

2. Попова О.П., Петрова М.С., Чистякова Г.Г. и др. Клиника коклюша и серологические варианты коклюшного микроба в современных условиях. Эпидемиол. и инфекц. болезни. 2005; 1: 44–46.

3. Семёнов Б.В., Захарова Н.С., Мазурова И.К. Подъём заболеваемости коклюшем на фоне массовой вакцинации. Гипотезы, объясняющие этот феномен. Микробиология. 2003; 6: 70–73.

4. Van Loo I.H.M., van der Heide G.J., Nagelkerke N.J.D. et al. Temporal Trends in the Population Structure of Bordetella pertussis during 1949–1996 in a Highly Vaccinated Population. J. Infect. Dis. 1999; 179: 915–923.

5. Mooi F.R., van Oirschot H., Heuvelman K. et al. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in the Netherlands: temporal trends and evidence for vaccine driven evolution. Infect. Immun. 1998; 66: 670–675.

6. Mooi F.R., He Q., van Oirschot H., Mertsola J. Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland. Infect. Immun. 1999; 67 (6): 3133–3134.

7. Hardwick T.H., Cassiday P., Weyant R.S. et al. Changes in predominance and diversity of genomic subtypes of Bordetella pertussis isolated in the United States, 1935–1999. Emerg. Infect. Dis. 2002; 8 (1): 44–49.

8. Бабаченко И.В., Курова Н.Н., Ценева Г.Я. Молекулярно-генетические и клинические особенности коклюшной и паракоклюшной инфекций в Санкт-Петербурге. Эпидемиология и инфекционные болезни. 2005; 6: 41–45.

9. Mooi F.R., Hallander H., von Konig C.H.W., Hoet B., Guiso N. Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur. J. Clin. Microbiol. Infect. Dis. 2000; 19: 174–181.

10. Preston N.W. Essential immunogens in human pertussis: the role of fimbriae. Developments in Biological Standartization. 1983; 51: 137–141.

11. Weber C., Boursaux-Eude C., Coralie G. et al. Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective wholeBcell vaccine has been used for more than 30 years. J. Clin. Microbiol. 2001; 39: 4396–4403.

12. Попова О.П., Селезнева Т.С., Милюкова В.И. Клинико-эпидемиологические аспекты коклюшной инфекции в современных условиях. Эпидемиология и инфекционные болезни. 1999; 3: 24–26.


Review

For citations:


Babachenko I., Kurova N., Tseneva G. PERTUSSIS INFECTION AMIDST ANTIGENIC DRIFTING OF BORDETELLA PERTUSSIS. Current Pediatrics. 2006;5(6):24-27.

Views: 795


ISSN 1682-5527 (Print)
ISSN 1682-5535 (Online)